News Chart CANbridge Pharmaceuticals Inc.

Equities

1228

KYG1821D1097

Delayed Hong Kong S.E. Other stock markets 21:41:00 2024-05-19 EDT			5-day change	1st Jan Change
0.33 ^HKD	-7.04%		-4.35%	-66.67%

04-23	Canbridge Pharmaceuticals Shelves Glioblastoma Drug After Phase II Clinical Trials	MT
04-22	CANbridge Pharmaceuticals Inc. Announces Results of CAN008 Phase II Clinical Trial for the Treatment of Glioblastoma Multiforme	CI

b137c6ed0bc5e4c5f25861858b827.nD-_dbSRgXRZPQDvVz2IobITlhAo52w1oQ6ScHC0OIM.8QqGPuXezQBpbzKCE0z984VZ_3xFlz1BlX_kFzvaCvvUBtVE49bmFxhaWQ~cf0ab772c43e584f2fdb73e10fb77689